5-Fluorocytosine resistance in clinical isolates of Cryptococcus neoformans
- PMID: 2696871
5-Fluorocytosine resistance in clinical isolates of Cryptococcus neoformans
Abstract
Thirty six clinical isolates of Cryptococcus neoformans were tested for their susceptibility to 5-fluorocytosine and amphotericin B by the determination of minimum inhibitory concentrations and minimum fungicidal concentrations. 22.2% of the isolates were resistant to 5-fluorocytosine and 36.1% indicated 5-fluorocytosine tolerance. All strains were sensitive to amphotericin B.
Similar articles
-
In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.Arch Pathol Lab Med. 1988 Feb;112(2):161-2. Arch Pathol Lab Med. 1988. PMID: 3276290
-
Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.Antimicrob Agents Chemother. 2006 Jan;50(1):113-20. doi: 10.1128/AAC.50.1.113-120.2006. Antimicrob Agents Chemother. 2006. PMID: 16377675 Free PMC article.
-
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.Mycoses. 2006 Jul;49(4):324-30. doi: 10.1111/j.1439-0507.2006.01242.x. Mycoses. 2006. PMID: 16784448
-
The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans.Crit Rev Microbiol. 1987;15(1):45-56. doi: 10.3109/10408418709104447. Crit Rev Microbiol. 1987. PMID: 3319420 Review.
-
Septic arthritis due to Cryptococcus neoformans.J Infect. 1988 Sep;17(2):139-45. doi: 10.1016/s0163-4453(88)91683-0. J Infect. 1988. PMID: 3053912 Review.
Cited by
-
Surface-associated plasminogen binding of Cryptococcus neoformans promotes extracellular matrix invasion.PLoS One. 2009 Jun 3;4(6):e5780. doi: 10.1371/journal.pone.0005780. PLoS One. 2009. PMID: 19492051 Free PMC article.